## DisclosureEquityIncentivePlansAdditionalInformationDetail

**Year Ended**

|  | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
| --- | --- | --- | --- |
| **    Award Type** |  |  |  |
| **      Equity Award** |  |  |  |
| **    Plan Name** |  |  |  |
| **      Plan Name** |  |  |  |
| **    Title of Individual** |  |  |  |
| **      Relationship to Entity** |  |  |  |
| **    Major Types of Debt and Equity Securities** |  |  |  |
| **      Major Types of Debt and Equity Securities** |  |  |  |
| **    Vesting** |  |  |  |
| **      Vesting** |  |  |  |
|       Vesting period, in years | P4Y |  |  |
| *        Chief Executive Officer* | 3 years |  |  |
|       Contractual term of stock options, in years | P10Y |  |  |
|       Shares available for grant |  |  |  |
|       Aggregate intrinsic value of options outstanding |  |  |  |
|       Intrinsic value of options exercisable |  |  |  |
|       Intrinsic value of options vested and expected to vest |  |  |  |
|       Total intrinsic value of options exercised | 446,900 | 294,000 |  |
|       Aggregate intrinsic value of RSUs |  |  |  |
| *        Restricted stock units* |  |  |  |
|       Weighted-average grant-date fair value for option awards granted | 0.09 | 0.04 | 0.02 |
|       Weighted-average grant-date fair value for ESPP granted |  |  |  |
| *        Restricted stock units* | 0.22 | 0.16 |  |
| *        Employee stock purchase plan* | 0.07 | 0.02 | 0.01 |
|       Percentage of fully-diluted shares granted on approval |  |  |  |
| *        Chief Executive Officer* |  |  |  |
|       Number of stock options granted | 1,432 | 2,644 | 11,855 |
| *        Chief Executive Officer* |  |  |  |
| *        2010 Members of senior management award* |  |  |  |
|       Portion of options vested during period |  |  |  |
| *        Chief Executive Officer* |  |  |  |
|       Portion of remaining options scheduled to vested monthly basis |  |  |  |
| *        Chief Executive Officer* |  |  |  |
|       Additional percentage of fully-diluted shares granted on approval |  |  |  |
| *        Chief Executive Officer* |  |  |  |
|       Stock options with vesting schedule based on attainment of performance objectives |  |  |  |
| *        Chief Executive Officer* |  |  |  |
|       Portion of stock options scheduled to vest upon successful completion of performance objectives |  |  |  |
| *        Model S Engineering Prototype* | 0.00 |  |  |
| *        Model S Validation Prototype* | 0.00 |  |  |
| *        First Model S Production Vehicle* | 0.00 |  |  |
| *        10,000th Model S Production Vehicle* | 0.00 |  |  |
| *        First Model X Production Vehicle* | 0.00 |  |  |
| *        12-month period* | 0.00 |  |  |
| *        First Gen III Production Vehicle* | 0.00 |  |  |
| *        Three year period* | 0.00 |  |  |
|       Stock-based compensation expense | 156,496 | 80,737 | 50,145 |
| *        2012 CEO Grant* | 25,000 | 14,500 | 1,300 |
| *        Performance-based Stock Option Grant* | 10,700 |  |  |
| *        Chief Executive Officer* |  | 400 | 4,200 |
| *        2010 Members of senior management award* |  | 800 | 1,400 |
|       Number of stock options granted |  |  |  |
| *        2012 CEO Grant* |  |  |  |
| *        Performance-based Stock Option Grant* |  |  |  |
|       CEO Grant consists of number of vesting tranches |  |  |  |
| *        2012 CEO Grant* |  |  |  |
|       Market capitalization |  |  |  |
| *        2012 CEO Grant* |  |  |  |
|       Initial market capitalization |  |  |  |
| *        2012 CEO Grant* |  |  |  |
|       Gross margin |  |  |  |
| *        2012 CEO Grant* | 0.00 |  |  |
| *        Three year period* | 0.00 |  |  |
|       Aggregate number of vehicle production | 100 |  |  |
| *        Eighth Tranche* | 100 |  |  |
| *        Ninth Tranche* | 200 |  |  |
| *        Tenth Tranche* | 300 |  |  |
| *        12-month period* | 100 |  |  |
|       Vesting period of grant |  |  |  |
| *        2012 CEO Grant* | P10Y |  |  |
|       Risk-free interest rate |  |  |  |
| *        Stock options* | 0.00 | 0.00 | 0.00 |
| *        Employee stock purchase plan* | 0.00 | 0.00 | 0.00 |
| *        C E O Grant* | 0.00 |  |  |
|       Expected term, in years |  |  |  |
| *        C E O Grant* | P10Y |  |  |
|       Expected volatility |  |  |  |
| *        Stock options* | 0.00 | 0.00 | 0.00 |
| *        Employee stock purchase plan* | 0.00 | 0.00 | 0.00 |
| *        C E O Grant* | 0.00 |  |  |
|       Dividend yield |  |  |  |
| *        Stock options* |  |  |  |
| *        Employee stock purchase plan* |  |  |  |
| *        C E O Grant* |  |  |  |
|       Number of vesting tranches |  |  |  |
| *        2012 CEO Grant* | 0 |  |  |
| *        Performance-based Stock Option Grant* |  |  |  |
|       Unrecognized compensation expense |  |  |  |
|       Weighted-average period of recognition of unrecognized compensation, in years | P5Y |  |  |
|       Percentage of payroll deductions of employees eligible compensation | 0.00 |  |  |
|       Percentage of discount on purchase price of shares lower than fair market value | 0.00 |  |  |
|       Number of shares issued under ESPP | 164 | 519 | 374 |
| *        Common Stock* | 164 | 519 | 374 |
|       Number of shares issued under ESPP, value | 28,571 | 13,849 | 8,389 |
| *        Additional Paid-In Capital* | 28,571 | 13,848 | 8,388 |
| *        Common Stock* |  | 1 | 1 |
|       Shares available for grant |  |  |  |
| *        Employee Stock* |  |  |  |
|       Number of shares available for issuance under ESPP |  |  |  |
| *        Employee Stock* |  |  |  |